SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-026877
Filing Date
2024-03-28
Accepted
2024-03-28 07:10:03
Documents
2
Period of Report
2024-03-28

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0202754-6k_purplebio.htm 6-K 14192
2 PURPLE BIOTECH TO PRESENT NEW DATA ON ITS ONCOLOGY DRUG NT219 AT AACR 2024 ea020275401ex99-1_purplebio.htm EX-99.1 15875
  Complete submission text file 0001213900-24-026877.txt   31343
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 24793469
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)